Sanders Morris Harris’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,360
| Closed | -$506K | – | 218 |
|
|
2025
Q1 | $506K | Hold |
13,360
| – | – | 0.08% | 155 |
|
|
2024
Q4 | $452K | Hold |
13,360
| – | – | 0.07% | 173 |
|
|
2024
Q3 | $546K | Hold |
13,360
| – | – | 0.09% | 145 |
|
|
2024
Q2 | $514K | Hold |
13,360
| – | – | 0.08% | 153 |
|
|
2024
Q1 | $573K | Buy |
13,360
+560
| +4% | +$24K | 0.11% | 143 |
|
|
2023
Q4 | $505K | Sell |
12,800
-560
| -4% | -$22.1K | 0.25% | 107 |
|
|
2023
Q3 | $481K | Hold |
13,360
| – | – | 0.1% | 157 |
|
|
2023
Q2 | $472K | Buy |
+13,360
| New | +$472K | 0.1% | 142 |
|
|
2021
Q2 | – | Sell |
-16,560
| Closed | -$739K | – | 323 |
|
|
2021
Q1 | $739K | Sell |
16,560
-12,240
| -43% | -$546K | 0.16% | 113 |
|
|
2020
Q4 | $1.34M | Hold |
28,800
| – | – | 0.3% | 65 |
|
|
2020
Q3 | $1.35M | Buy |
28,800
+12,800
| +80% | +$599K | 0.37% | 60 |
|
|
2020
Q2 | $816K | Buy |
+16,000
| New | +$816K | 0.4% | 33 |
|
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$235K | – | 213 |
|
|
2019
Q4 | $235K | Hold |
4,000
| – | – | 0.05% | 248 |
|
|
2019
Q3 | $204K | Hold |
4,000
| – | – | 0.05% | 256 |
|
|
2019
Q2 | $201K | Buy |
+4,000
| New | +$201K | 0.05% | 253 |
|
|
2016
Q2 | – | Sell |
-21,645
| Closed | -$1.1M | – | 274 |
|
|
2016
Q1 | $1.1M | Buy |
+21,645
| New | +$1.1M | 0.19% | 108 |
|